Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Grifols S.A. GRF.MC ES Equity

Health Care · FY ends Dec 31
€10.06
+0.02 (+0.20%)
EUR · as of 2026-08-27 · marketstack

Grifols S.A. (BME: GRF.MC) closed at €10.06, +0.2%, on 2026-08-27, with a return on equity of 2.8%, a net margin of 2.2% and 3-year sales growth of 13.5%. Institutional ownership, earnings history and filed financials are on the tabs below.

Short interest· FINRA consolidated · settlement 2026-08-14· GRFSGrifols SA

6 settlement cycles

Short interest shown for the US-listed sibling GRFS — FINRA covers US listings; figures are that line's shares.

Shares short3.5M
% of shares out
Days to cover9.8
Δ vs 2026-07-31+1.8%
▲ 6.3M shares shortline top = 9.9d to cover2026-05-29: 5.9M short · 9.8d to cover2026-052026-06-15: 6.0M short · 9.9d to cover2026-062026-06-30: 6.1M short · 9.4d to cover2026-062026-07-15: 6.3M short · 8.2d to cover2026-072026-07-31: 3.5M short · 3.8d to cover2026-072026-08-14: 3.5M short · 9.8d to cover2026-08

bars = shares short · line = days to cover (own scale)

% of shares outstanding suppressed: the listed line's share basis (ADR/depositary) differs from the reported ordinary share count.

SettlementShares shortΔ vs priorAvg daily volumeDays to cover
2026-08-143,516,392+1.8%358,9849.8
2026-07-313,455,645-45.5%917,6613.8
2026-07-156,340,082+3.7%776,2768.2
2026-06-306,113,884+1.8%652,3329.4
2026-06-156,007,590+2.0%606,6079.9
2026-05-295,890,416-1.3%599,5159.8

FINRA Rule 4560 · twice monthly, published ~a week later.

Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.